[Event Report] The Global Expert Meeting “The Future of the Olympic Games–The Policies Needed to Resume Large-Scale International Events” (March 5, 2021)
date : 4/5/2021
Tags: Other activities, Vaccinations
******** The full report published April 5, 2021.
For more information, please refer to the PDF.
■Overview:
Health and Global Policy Institute (HGPI) will take advantage of its position as a neutral and independent global think tank to convene the COVID-19 Policy Agenda Series, a series of global expert meetings for discussing future COVID-19 measures with experts from abroad.
These meetings will provide opportunities for those experts to freely exchange opinions from positions of equality on best methods to promote immunization among the public, how to communicate to the public, the current status of surveillance and testing systems, efforts to improve policies, and the ideal structure of international quarantine and inspection systems. This knowledge will be required to hold the 2021 Tokyo Olympic and Paralympic Games and other international events, to enable the Government to effectively communicate risk to the public, and to improve epidemiological database systems. In the future, we will make efforts to connect with experts around the world online to create more opportunities for international opinion exchanges.
At the first expert meeting, we deepened the discussion on advances that must be made to reach a national consensus on hosting large-scale international events, establishing systems for international collaboration, and policy developments needed to safely resume large-scale international events with the Tokyo Olympic and Paralympic Games in mind.
■Five recommendations synthesized from an international discussion involving industry, the Government, academia, and civil society (Summary):
Recommendation 1. To resume large-scale events, public understanding of all aspects of COVID-19 control should be promoted.
Recommendation 2. Quarantining at international points of entry and thorough observance of basic infectious disease control measures should continue. negative test results at time of departure or entry are not decisive infectious disease control measures.
Recommendation 3. A data-based infection management system that utilizes epidemiological databases and modeling should be built.
Recommendation 4. Testing systems should be diversified and expanded according to scientific knowledge.
Recommendation 5. The Tokyo Olympic and Paralympic Games should be held in a manner that demonstrates the new normal to the world.
(For more information, please refer to the PDF)
■Speakers (Title Omitted):
Hanako Jimi (Member, House of Councilors; Chief of Secretariat, Anti-COVID-19 Measures for Inbound Tourists at Head Office, the Novel Coronavirus Response Headquarters of the Liberal Democratic Party of Japan))
Cheong Wei Yang (Deputy Secretary (Special Projects), Ministry of Health, Singapore)
Alex Richard Cook (Associate Professor, at National University of Singapore, Saw Swee Hock School of Public Health)
Satoshi Kamayachi (Executive Director, Japan Medical Association)
Nobuhiko Okabe (Director General, Kawasaki City Institute for Public Health)
Naomi Sakurai (Cancer survivor; President, Cancer Solutions Co., Ltd)
Katsunori Yanagihara (Professor, Department of Laboratory Medicine, School of Dentistry and Pharmaceutical Sciences, Nagasaki University; Examination and Diagnosis Team, Tokyo Center for Infectious Disease Control and Prevention (iCDC) Expert Board)
Hidemasa Nakamura (GDO<Games Delivery Officer> / Executive Director of Sports, The Tokyo Organising Committee of the Olympic and Paralympic Games)
Kazuhiro Tateda (Professor, Department of Microbiology and Infectious Diseases, Toho University; President, The Japanese Society for Clinical Microbiology)
Keizo Takemi (Member, House of Councilors; Chairperson, Infectious Disease Measures Governance Subcommittee, the Novel Coronavirus Response Headquarters of the Liberal Democratic Party of Japan)
Kiyoshi Kurokawa (Chairman, HGPI)
Ryoji Noritake (CEO, Board Member, HGPI)
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Survey Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Preliminary Version) (September 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
- [Policy Recommendations] Three Necessary Perspectives for Formulating the Basic Plan for the Promotion of Policies on Dementia: Creating a Society That is Inclusive for All People at All Times (April 1, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
Featured Posts
-
2024-09-26
[Registration Open] HGPI Salon Special Edition “The 2024 U.S. Presidential Election’s Impact on Japan’s Healthcare Policies: Future Implications for U.S.-China Relations and U.S.-Japan Cooperation” (October 28, 2024)
-
2024-10-07
[Registration Open] International Dialogue “Fostering Community and Citizen-led Approaches to AMR: Lessons from Antibiotic Smart Sweden” (October 25, 2024)
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Open] HGPI Salon Special Edition “Overcoming Infectious Diseases through Partnership: Focusing on examples of promoting technology transfer of antimicrobial agents” (October 21, 2024)
-
2024-10-09
[Registration Open] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)